{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32271583", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "04", "Day": "21"}], "ELocationID": ["10.1021/acs.langmuir.0c00298"], "Journal": {"ISSN": "1520-5827", "JournalIssue": {"Volume": "36", "Issue": "17", "PubDate": {"Year": "2020", "Month": "May", "Day": "05"}}, "Title": "Langmuir : the ACS journal of surfaces and colloids", "ISOAbbreviation": "Langmuir"}, "ArticleTitle": "Surface Modification Using Ultraviolet-Ozone Treatment Enhances Acute Drug Transfer in Drug-Coated Balloon Therapy.", "Pagination": {"StartPage": "4645", "EndPage": "4653", "MedlinePgn": "4645-4653"}, "Abstract": {"AbstractText": ["Endovascular deployment of drug-coated balloons (DCB) is an emerging strategy for the revascularization of arterial disease. Randomized clinical trials have demonstrated DCB effectiveness, but a recent meta-analysis reported increased mortality risk in humans with use of DCBs containing the common antiproliferative drug paclitaxel. While many factors could have contributed to adverse outcomes, current DCB designs have poor drug delivery efficiency, risk of systemic toxicity, and limited potential to retain therapeutic drug concentrations within the arterial wall following the procedure. Our study focuses on developing a strategy to enhance acute drug transfer from the balloon to the arterial wall over the short procedural window (\u223c30-120 s). We employed ultraviolet-ozone plasma (UVO) treatment to increase the hydrophilicity of a prototypical balloon material (Nylon-12) and subsequently applied a urea-paclitaxel coating previously shown to undergo favorable adhesive interactions with the arterial wall under simulated ex-vivo deployment. A series of assays were performed to characterize our experimental DCBs in terms of UVO-induced alterations in balloon surface hydrophobicity, formed coating microstructure, coating stability, and acute drug transfer to the arterial wall. Obtained results suggest that the UVO-based surface modification of angioplasty balloons is a promising design strategy and highlights the critical role of coating microstructure in determining the drug transfer efficiency in DCB therapy."]}, "AuthorList": [{"Identifier": ["0000-0002-4670-3997"], "AffiliationInfo": [], "LastName": "Azar", "ForeName": "Dara", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lott", "ForeName": "Jared T", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jabbarzadeh", "ForeName": "Ehsan", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Shazly", "ForeName": "Tarek", "Initials": "T"}, {"Identifier": ["0000-0002-5312-8644"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hariri Institute for Computing and Computational Science and Engineering, Boston University, Boston, Massachusetts 02215, United States."}, {"Identifier": [], "Affiliation": "Boston University Alzheimer's Disease Center, Boston, Massachusetts 02118, United States."}], "LastName": "Kolachalama", "ForeName": "Vijaya B", "Initials": "VB"}], "GrantList": [{"GrantID": "P20 GM103499", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL159620", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Langmuir", "NlmUniqueID": "9882736", "ISSNLinking": "0743-7463"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cardiovascular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Coated Materials, Biocompatible"}, {"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "P88XT4IS4D", "NameOfSubstance": "Paclitaxel"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cardiovascular Agents"}, {"QualifierName": [], "DescriptorName": "Coated Materials, Biocompatible"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Paclitaxel"}, {"QualifierName": [], "DescriptorName": "Peripheral Arterial Disease"}, {"QualifierName": [], "DescriptorName": "Pharmaceutical Preparations"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rosenfield K; Jaff MR; White CJ; Rocha-Singh K; Mena-Hurtado C; Metzger DC; Brodmann M; Pilger E; Zeller T; Krishnan P; Gammon R; Muller-Hulsbeck S; Nehler MR; Benenati JF; Scheinert D; Investigators L. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N. Engl. J. Med. 2015, 373 (2), 145\u2013153.", "ArticleIdList": ["26106946"]}, {"Citation": "Tepe G; Zeller T; Albrecht T; Heller S; Schwarzwalder U; Beregi JP; Claussen CD; Oldenburg A; Scheller B; Speck U Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N. Engl. J. Med. 2008, 358 (7), 689\u201399.", "ArticleIdList": ["18272892"]}, {"Citation": "Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014, 7 (1), 10\u20139.", "ArticleIdList": ["24456716"]}, {"Citation": "Tepe G; Laird J; Schneider P; Brodmann M; Krishnan P; Micari A; Metzger C; Scheinert D; Zeller T; Cohen DJ; Snead DB; Alexander B; Landini M; Jaff MR; Investigators IPST Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015, 131 (5), 495\u2013502.", "ArticleIdList": ["PMC4323569", "25472980"]}, {"Citation": "Giacoppo D; Alfonso F; Xu B; Claessen B; Adriaenssens T; Jensen C; Perez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Schunkert H; Colleran R; Kukla P; Jimenez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA, Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). Eur. Heart J. 2019, DOI: 10.1093/eurheartj/ehz594.", "ArticleIdList": ["10.1093/eurheartj/ehz594", "PMC7706792", "31511862"]}, {"Citation": "Rissanen TT; Uskela S; Eranen J; Mantyla P; Olli A; Romppanen H; Siljander A; Pietila M; Minkkinen MJ; Tervo J; Karkkainen JM; investigators D. t. Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet 2019, 394 (10194), 230\u2013239.", "ArticleIdList": ["31204115"]}, {"Citation": "Katsanos K; Spiliopoulos S; Kitrou P; Krokidis M; Karnabatidis D. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Am. Heart Assoc. 2018, 7 (24), No. e011245.", "ArticleIdList": ["PMC6405619", "30561254"]}, {"Citation": "Anderson JA; Lamichhane S; Remund T; Kelly P; Mani G. Preparation, characterization, in vitro drug release, and cellular interactions of tailored paclitaxel releasing polyethylene oxide films for drug-coated balloons. Acta Biomater. 2016, 29, 333\u2013351.", "ArticleIdList": ["26432441"]}, {"Citation": "Lamichhane S; Anderson J; Remund T; Kelly P; Mani G. Dextran sulfate as a drug delivery platform for drug-coated balloons: Preparation, characterization, in vitro drug elution, and smooth muscle cell response. J. Biomed. Mater. Res, Part B 2016, 104 (7), 1416\u201330.", "ArticleIdList": ["PMC5054853", "26227252"]}, {"Citation": "Kolachalama VB; Pacetti SD; Franses JW; Stankus JJ; Zhao HQ; Shazly T; Nikanorov A; Schwartz LB; Tzafriri AR; Edelman ER Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy. Circulation 2013, 127 (20), 2047\u201355.", "ArticleIdList": ["PMC3748613", "23584359"]}, {"Citation": "Mandal PK; Sarifuddin Kolachalama, V. B. Computational Model of Drug-Coated Balloon Delivery in a Patient-Specific Arterial Vessel with Heterogeneous Tissue Composition. Cardiovasc Eng. Technol. 2016, 7 (4), 406\u2013419.", "ArticleIdList": ["PMC9351813", "27443840"]}, {"Citation": "Kempin W; Kaule S; Reske T; Grabow N; Petersen S; Nagel S; Schmitz KP; Weitschies W; Seidlitz A. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons. Eur. J. Pharm. Biopharm. 2015, 96, 322\u20138.", "ArticleIdList": ["26318979"]}, {"Citation": "Seidlitz A; Kotzan N; Nagel S; Reske T; Grabow N; Harder C; Petersen S; Sternberg K; Weitschies W. In vitro determination of drug transfer from drug-coated balloons. PLoS One 2013, 8 (12), No. e83992.", "ArticleIdList": ["PMC3877149", "24391863"]}, {"Citation": "Speck U; Stolzenburg N; Peters D; Scheller B. How does a drug-coated balloon work? Overview of coating techniques and their impact. Journal of Cardiovascular Surgery 2016, 57 (1), 3\u201311.", "ArticleIdList": ["26771720"]}, {"Citation": "Cortese B; Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data. Int. J. Cardiol. 2012, 161 (1), 4\u201312.", "ArticleIdList": ["21955612"]}, {"Citation": "Hehrlein C. Drug-coated balloons\u2013the importance of packing and dosing antiproliferative drugs. Catheter Cardiovasc Interv 2015, 86 (2), 287\u20138.", "ArticleIdList": ["26198065"]}, {"Citation": "Chang GH; Azar DA; Lyle C; Chitalia VC; Shazly T; Kolachalama VB Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy. Sci. Rep. 2019, 9 (1), 6839.", "ArticleIdList": ["PMC6497887", "31048704"]}, {"Citation": "Richey T; Iwata H; Oowaki H; Uchida E; Matsuda S; Ikada Y. Surface modification of polyethylene balloon catheters for local drug delivery. Biomaterials 2000, 21 (10), 1057\u201365.", "ArticleIdList": ["10768758"]}, {"Citation": "Chen P; Tang M; Zhu W; Yang L; Wen S; Yan C; Ji Z; Nan H; Shi Y. Systematical mechanism of Polyamide-12 aging and its micro-structural evolution during laser sintering. Polym. Test. 2018, 67 (December 2017), 370\u2013379."}, {"Citation": "Mazov I; Kuznetsov VL; Simonova IA; Stadnichenko AI; Ishchenko AV; Romanenko AI; Tkachev EN; Anikeeva OB Oxidation behavior of multiwall carbon nanotubes with different diameters and morphology. Appl. Surf. Sci. 2012, 258 (17), 6272\u20136280."}, {"Citation": "Verkuijlen ROF; Van Dongen MHA; Stevens AAE; Van Geldrop J; Bernards JPC Surface modification of polycarbonate and polyethylene naphtalate foils by UV-ozone treatment and \u03bcplasma printing. Appl. Surf. Sci. 2014, 290, 381\u2013387."}, {"Citation": "Xue C; Lott JT; Kolachalama VB Estimation of Size and Contact Angle of Evaporating Sessile Liquid Drops Using Texture Analysis. Langmuir 2019, 35 (10), 3672\u20133679.", "ArticleIdList": ["PMC9351812", "30707587"]}, {"Citation": "Woolford SE; Tran M; NguyenPho A; McDermott MK; Oktem B; Wickramasekara S. Optimization of balloon coating process for paclitaxel coated balloons via micro-pipetting method. Int. J. Pharm. 2019, 554, 312\u2013321.", "ArticleIdList": ["30395954"]}, {"Citation": "Bradley RH; Clackson IL; Sykes DE UV ozone modification of wool fibre surfaces. Appl. Surf. Sci. 1993, 72 (2), 143\u2013147."}, {"Citation": "K\u0142onica M; Kuczmaszewski J; Kwiatkowski MP; Ozonek J. Polyamide 6 surface layer following ozone treatment. Int. J. Adhes. Adhes. 2016, 64, 179\u2013187."}, {"Citation": "Berger P; Karpel Vel Leitner N; Dor\u00e9 M; Legube B\u0301. Ozone and hydroxyl radicals induced oxidation of glycine. Water Res. 1999, 33 (2), 433\u2013441."}, {"Citation": "Hutt DA; Leggett GJ Functionalization of hydroxyl and carboxylic acid terminated self-assembled monolayers. Langmuir 1997, 13 (10), 2740\u20132748."}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32271583", "NIHMS1825989", "PMC9337626", "10.1021/acs.langmuir.0c00298"]}}], "PubmedBookArticle": []}